Drug details

Aralast NP (alpha1-proteinase inhibitor (human) liquid for intravenous infusion)

type of Alpha-1 proteinase inhibitor, Pulmonary, Other

Aralast NP [Alpha1-Proteinase Inhibitor (Human)] is an Alpha1-Proteinase Inhibitor (Human) (Alpha1-PI) indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital deficiency of Alpha1-PI (alpha-antitrypsin deficiency). Aralast NP increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1-PI.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• lightheadedness,
• chills,
• body aches,
• wheezing,
• vision changes
• flu symptoms,
• sores in your mouth and throat,
• pain or burning when you urinate,
• chest pain or pressure, and

The following drugs are related to Aralast NP, either as a replacement or used together:

• Glassia (alpha1 proteinase inhibitor (human) for intravenous administration)